Comment on CMS-2026-1255-0001

Summary: The National Health Council (NHC), an organization representing nearly 200 health-related organizations and businesses, supports the proposed rule to extend interoperability and prior authorization reforms to drugs. They argue that the proposal is a constructive step toward reducing administrative burdens and improving patient access to timely, medically necessary care.